References
- Benson, R. et al., ‘Re-irradiation for head and neck squamous cell carcinoma’, Journal of the Egyptian National Cancer Institute, 2017. 29(1): pp. 1–9.
- Takiar, V. et al., ‘Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses’, International Journal of Radiation Oncology, Biology, Physics, 2016. 95(4): pp. 1117–31.
- NCCN, ‘Head and Neck Cancers’, in NCCN Clinical Practice Guidelines in Oncology. 2022.
- Vermorken, J.B. et al., ‘Platinum-based chemotherapy plus cetuximab in head and neck cancer’, N Engl J Med, 2008. 359(11): pp. 1116–27.
- Ward, M.C. et al., ‘Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria’, Int J Radiat Oncol Biol Phys, 2022. 113(4): pp. 759–86.
- Janot, F. et al., ‘Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma’, J Clin Oncol, 2008. 26(34): pp. 5518–23.
- Ward, M.C. et al., ‘Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative’, Int J Radiat Oncol Biol Phys, 2018. 100(3): pp. 586–94. doi:10.1016/j.ijrobp.2017.06.012
- Caudell, J.J. et al., ‘Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis’, Int J Radiat Oncol Biol Phys, 2018. 100(3): pp. 606–617. doi:10.1016/j.ijrobp.2017.11.036
- Bots, W.T.C. et al., ‘Reirradiation of head and neck cancer: Long-term disease control and toxicity’, Head & Neck, 2017. 39(6): pp. 1122–1130. doi:10.1002/hed.24733
- Nieder, C. & J. Langendijk, Re-Irradiation: New Frontiers (Medical Radiology). 2nd ed. 2017: Springer.
- Spencer, S.A. et al., ‘Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck’, Head & Neck, 2008. 30(3): pp. 281–88.
- Langer, C.J. et al., ‘Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911’, J Clin Oncol, 2007. 25(30): pp. 4800–05.
- Salama, J.K. et al., ‘Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma’, Int J Radiat Oncol Biol Phys, 2006. 64(2): pp. 382–91.
- Lee, N. et al., ‘Salvage re-irradiation for recurrent head and neck cancer’, Int J Radiat Oncol Biol Phys, 2007. 68(3): pp. 731–40.
- De Crevoisier, R. et al., ‘Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients’, J Clin Oncol, 1998. 16(11): pp. 3556–62.
- Bonner, J.A. et al., ‘Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck’, N Engl J Med, 2006. 354(6): pp. 567–78.
- Sulman, E.P. et al., ‘IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes’, Int J Radiat Oncol Biol Phys, 2009. 73(2): pp. 399–409.
- Mortensen, H.R. et al., ‘Aspiration pneumonia in patients treated with radiotherapy for head and neck cancer’, Acta Oncol., 2013. 52(2): pp. 270–76. doi:10.3109/0284186X.2012.742205
- Anschuetz, L. et al., ‘Long-term functional outcome after laryngeal cancer treatment’, Radiation Oncology, 2019. 14(1): p. 101.
- Kamran, S. & A. Viswanathan, ‘Risk and Prevention of Radiation-Induced Cancers’, in: Demos Medical, Radiation Therapy Treatment Effects. 2017: Springer.
- Kumar, S., ‘Second malignant neoplasms following radiotherapy’, International journal of environmental research and public health, 2012. 9(12): pp. 4744–59.